Izumi S, Iwashita M, Makino T, Saito S, Sakamoto S, Takeda Y, Nozawa S
Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo, Japan.
Endocrinol Jpn. 1991 Apr;38(2):195-204. doi: 10.1507/endocrj1954.38.195.
The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent activator of Ca(2+)- and phospholipid-dependent protein kinase (C kinase), stimulates luteinizing hormone (LH) release from rat pituitary cells. The actions of TPA upon LH release were compared with those of the GnRH superagonist [D-Ala6] des-Gly10-GnRH N-ethylamide (GnRHa) in cultured pituitary cells. LH release was stimulated by 0.1 nM TPA and the maximum response at 10 nM TPA was 50% of the LH response to GnRHa. The ED50 values for TPA and GnRHa were 1.2 and 0.037 nM, respectively, and the maximum stimulatory effects of TPA and GnRHa on LH release were not additive. GnRHa-stimulated LH release was decreased by calmodulin (CaM) antagonists including pimozide, trifluoperazine, W5 and W7, being most effectively reduced (by 70%) by 10 microM pimozide. In contrast to their inhibition of GnRH action, these antagonists enhanced TPA-stimulated LH release, so that 10 microM pimozide and W7 doubled the maximum LH response. The potent GnRH antagonist [Ac-D-p-Cl-Phe1.2, D-Trp3, D-Lys6, D-Ala10]GnRH, which completely inhibited GnRHa-stimulated LH release with ID50 of 6.8 nM, also reduced maximum TPA-stimulated LH release by about 50%. These results suggest that both Ca2+/CaM and C kinase pathways are involved in the LH release mechanism, and indicate that C kinase plays a major role in the action of GnRH upon gonadotropin secretion. The synergism between CaM antagonists and TPA suggests that blockade of CaM-mediated processes leads to enhanced activation of the C kinase pathway, possibly by removal of an inhibitory influence. Furthermore, the partial inhibition of TPA-stimulated LH release by a GnRH antagonist suggests that the pathway(s), specifically connected with LH release in the diverse effects of C kinase, might be locked by the continuous receptor inactivation by antagonist and indicates the complicated pathways which diverge from the receptor and converge into specific cellular response.
佛波酯12 - O -十四酰佛波醇-13 -乙酸酯(TPA)是一种强力的钙(Ca2+)和磷脂依赖性蛋白激酶(C激酶)激活剂,可刺激大鼠垂体细胞释放促黄体生成素(LH)。在培养的垂体细胞中,比较了TPA对LH释放的作用与促性腺激素释放激素(GnRH)超级激动剂[D - Ala6]去甘氨酸10 - GnRH N -乙酰胺(GnRHa)的作用。0.1 nM的TPA可刺激LH释放,10 nM TPA时的最大反应是LH对GnRHa反应的50%。TPA和GnRHa的半数有效剂量(ED50)值分别为1.2和0.037 nM,且TPA和GnRHa对LH释放的最大刺激作用无相加性。包括匹莫齐特、三氟拉嗪、W5和W7在内的钙调蛋白(CaM)拮抗剂可降低GnRHa刺激的LH释放,其中10 μM匹莫齐特的抑制作用最为有效(降低70%)。与它们对GnRH作用的抑制相反,这些拮抗剂增强了TPA刺激的LH释放,因此10 μM匹莫齐特和W7使LH的最大反应增加了一倍。强效GnRH拮抗剂[Ac - D - p - Cl - Phe1,2, D - Trp3, D - Lys6, D - Ala10]GnRH可完全抑制GnRHa刺激的LH释放,半数抑制浓度(ID50)为6.8 nM,它也使TPA刺激的LH最大释放降低了约50%。这些结果表明,Ca2+/CaM和C激酶途径均参与LH释放机制,并表明C激酶在GnRH对促性腺激素分泌的作用中起主要作用。CaM拮抗剂与TPA之间的协同作用表明,CaM介导过程的阻断可能通过消除抑制性影响而导致C激酶途径的激活增强。此外,GnRH拮抗剂对TPA刺激的LH释放的部分抑制表明,在C激酶的多种作用中与LH释放特异性相关的途径可能因拮抗剂持续使受体失活而被阻断,这表明从受体发散并汇聚到特定细胞反应的途径较为复杂。